The global surgical snare market size was valued at USD 1.77 billion in 2023 and it is predicted to surpass around USD 2.63 billion by 2033 with a CAGR of 4.05% from 2024 to 2033.
The global surgical snare market has witnessed significant growth in recent years, driven by factors such as increasing prevalence of gastrointestinal disorders, rising demand for minimally invasive surgical procedures, and advancements in technology. Surgical snares are widely utilized in endoscopic procedures for the removal of polyps, tumors, and other abnormal tissues.
The growth of the surgical snare market is propelled by an increasing prevalence of gastrointestinal disorders, including colorectal cancer and inflammatory bowel disease, has led to a higher demand for surgical snares, which are essential tools for the removal of polyps and tumors during endoscopic procedures. Secondly, advancements in endoscopic techniques and instrument technology have significantly enhanced the efficacy and safety of procedures involving surgical snares, driving their adoption among healthcare providers. Additionally, the rising trend towards minimally invasive surgeries, characterized by shorter recovery times and reduced post-operative complications, has further fueled the demand for surgical snares.
Report Coverage | Details |
Revenue Share of North America in 2023 | 46% |
CAGR of Asia Pacific from 2024 to 2033 | 4.96% |
Revenue Forecast by 2033 | USD 2.63 billion |
Growth Rate from 2024 to 2033 | CAGR of 4.05% |
Base Year | 2023 |
Forecast Period | 2024 to 2033 |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
The single-use segment accounted for the largest revenue share of over 63% in 2023. The single-use snares include soft wire oval, crescent-shaped, oval, and hard wire oval snares. Various shapes and wire characteristics are required in various application areas, including thick wires for higher coagulation and hard snares for flat polyps. Increasing adoption of single-use instruments in healthcare facilities to ensure convenience and safety is expected to accelerate the growth of the segment.
The reusable segment is expected to witness the fastest growth at a CAGR of 4.25% over the forecast period. The rising demand for cost-effective and sustainable medical devices, coupled with the increasing focus on reducing medical waste and environmental impact, has fueled the adoption of reusable surgical snares. These devices offer advantages such as durability, ease of sterilization, and long-term cost savings for healthcare facilities.
The hospital's segment captured the largest revenue share of over 79% in 2023. The hospital segment is the largest revenue-generating segment due to the high surgery volume. According to the CDC, a steep increase in surgical procedures, such as angioplasty and kidney and liver transplants, has been observed in the past few years. Coupled with the growing incidence of trauma, hospitals' demand for surgical equipment has significantly increased in recent years.
The Ambulatory Surgical Centers (ASCs) segment is anticipated to register the fastest CAGR of 4.14% over the forecast period. It can be attributed to lower out-of-pocket costs, better patient accessibility, and decreased facility costs.
The GI endoscope segment held the largest revenue share of over 33% in 2023 and is expected to maintain its dominance over the forecast period. The increasing number of gastroscopies, the rising adoption of endoscopes for diagnosing and treating gastrointestinal (GI) diseases, and the availability of advanced products for gastroscopy are some of the factors boosting the use of gastroscopy.
The arthroscopy is expected to expand at the fastest CAGR of 4.46% over the forecast period. The adoption of arthroscopic procedures is expected to increase owing to the rising geriatric population at risk of age-related disorders, such as arthritis, and rising incidence of joint injuries, such as knee and shoulder. According to the Centers for Disease Control and Prevention estimates, about one in four adults, or about 58.5 million people in the U.S., have been diagnosed with arthritis by doctors.
Moreover, according to the estimates published by the Arthritis Foundation, the number of people with doctor-diagnosed arthritis is expected to be over 78 million by 2040. Hence, such factors are anticipated to provide significant growth opportunities for the market in the upcoming years.
North America accounted for the largest revenue share of over 46% in 2023. An increase in the adoption of new and advanced devices, a rise in the demand for minimally invasive surgical procedures, and a growth in chronic disease burden are among the factors driving the market. The growing burden of gastrointestinal disorders and cancer in the region is also one of the significant factors propelling the market growth. Rising cancer incidence and the availability of advanced diagnostic procedures are expected to boost market growth.
Furthermore, favorable reimbursement policies and well-established healthcare infrastructure in North America facilitate the adoption of surgical snares. The reimbursement coverage provided by the government and private insurance companies for endoscopic procedures, including the use of surgical snares, encourages healthcare facilities to invest in these devices.
The Asia Pacific region is experiencing rapid growth, exhibiting the highest CAGR of 4.96% over the forecast period. The region's increasing prevalence of gastrointestinal diseases and colorectal cancer has led to rising demand for surgical snares for effective diagnosis and treatment. Moreover, the growing geriatric population in countries like China and India has increased the need for minimally invasive surgical procedures, driving the demand for surgical snares.
By Usability
By Application
By End-use
By Region
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Usability Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Surgical Snare Market
5.1. COVID-19 Landscape: Surgical Snare Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Surgical Snare Market, By Usability
8.1. Surgical Snare Market, by Usability, 2024-2033
8.1.1 Single-use
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Reusable
8.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Surgical Snare Market, By Application
9.1. Surgical Snare Market, by Application, 2024-2033
9.1.1. GI Endoscope
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Laparoscopy
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Urology Endoscopy
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Gynecology Endoscopy
9.1.4.1. Market Revenue and Forecast (2021-2033)
9.1.5. Arthroscopy
9.1.5.1. Market Revenue and Forecast (2021-2033)
9.1.6. Bronchoscopy
9.1.6.1. Market Revenue and Forecast (2021-2033)
9.1.7. Mediastinoscopy
9.1.7.1. Market Revenue and Forecast (2021-2033)
9.1.8. Laryngoscopy
9.1.8.1. Market Revenue and Forecast (2021-2033)
9.1.9. Others
9.1.9.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Surgical Snare Market, By End-use
10.1. Surgical Snare Market, by End-use, 2024-2033
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Ambulatory Surgical Centers
10.1.2.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Surgical Snare Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Usability (2021-2033)
11.1.2. Market Revenue and Forecast, by Application (2021-2033)
11.1.3. Market Revenue and Forecast, by End-use (2021-2033)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Usability (2021-2033)
11.1.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.1.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Usability (2021-2033)
11.1.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.1.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Usability (2021-2033)
11.2.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Usability (2021-2033)
11.2.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Usability (2021-2033)
11.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Usability (2021-2033)
11.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Usability (2021-2033)
11.2.7.2. Market Revenue and Forecast, by Application (2021-2033)
11.2.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Usability (2021-2033)
11.3.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Usability (2021-2033)
11.3.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Usability (2021-2033)
11.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Usability (2021-2033)
11.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Usability (2021-2033)
11.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
11.3.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Usability (2021-2033)
11.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Usability (2021-2033)
11.4.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Usability (2021-2033)
11.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Usability (2021-2033)
11.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.6.3. Market Revenue and Forecast, by End-use (2021-2033)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Usability (2021-2033)
11.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
11.4.7.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Usability (2021-2033)
11.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.5.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Usability (2021-2033)
11.5.4.2. Market Revenue and Forecast, by Application (2021-2033)
11.5.4.3. Market Revenue and Forecast, by End-use (2021-2033)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Usability (2021-2033)
11.5.5.2. Market Revenue and Forecast, by Application (2021-2033)
11.5.5.3. Market Revenue and Forecast, by End-use (2021-2033)
Chapter 12. Company Profiles
12.1. Medtronic.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Boston Scientific Corporation.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Medline Industries, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Olympus Corporation.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Cook.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. CONMED Corporation
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Steris (U.S.)
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Merit Medical Systems
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Avalign Technologies.
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Hill-Rom Holdings, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms